We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
-2.94%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$4.68B
AUM Growth
-$141M
Cap. Flow
+$92.2M
Cap. Flow %
1.97%
Top 10 Hldgs %
29.84%
Holding
496
New
49
Increased
233
Reduced
148
Closed
29

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$28.9M
2
ORCL icon
Oracle
ORCL
+$24.3M
3
MDT icon
Medtronic
MDT
+$18.6M
4
EBAY icon
eBay
EBAY
+$15.1M
5
FISV
Fiserv Inc
FISV
+$7.95M

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Healthcare 17.18%
3 Financials 10.96%
4 Industrials 10.82%
5 Consumer Staples 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
276
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$901K 0.02%
1,837
+955
+108% +$465K
PSX icon
277
Phillips 66
PSX
$89.5B
$866K 0.02%
10,024
+3,897
+64% +$328K
BA icon
278
Boeing
BA
$184B
$856K 0.02%
4,468
+913
+26% +$183K
CLX icon
279
Clorox
CLX
$13.1B
$849K 0.02%
6,109
-390
-6% -$59.8K
EWBC icon
280
East-West Bancorp
EWBC
$18.2B
$849K 0.02%
10,740
-484
-4% -$40.8K
DEO icon
281
Diageo
DEO
$52.8B
$845K 0.02%
4,160
-792
-16% -$159K
DVY icon
282
iShares Select Dividend ETF
DVY
$23.7B
$840K 0.02%
6,559
+3,021
+85% +$377K
MORN icon
283
Morningstar
MORN
$7.33B
$825K 0.02%
3,021
REGN icon
284
Regeneron Pharmaceuticals
REGN
$82.1B
$825K 0.02%
1,181
+610
+107% +$386K
SDY icon
285
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$805K 0.02%
6,286
+1,990
+46% +$252K
TPL icon
286
Texas Pacific Land
TPL
$25.2B
$800K 0.02%
5,328
+189
+4% +$24.9K
TROW icon
287
T. Rowe Price
TROW
$24.3B
$799K 0.02%
5,283
+40
+0.8% +$6.18K
ASO icon
288
Academy Sports + Outdoors
ASO
$3.07B
$771K 0.02%
19,580
-18,475
-49% -$677K
OKE icon
289
Oneok
OKE
$57.7B
$766K 0.02%
10,840
-710
-6% -$45.4K
EOG icon
290
EOG Resources
EOG
$75.2B
$765K 0.02%
6,415
+2,029
+46% +$226K
AMLP icon
291
Alerian MLP ETF
AMLP
$13.3B
$760K 0.02%
19,833
-5,420
-21% -$199K
ELV icon
292
Elevance Health
ELV
$84.7B
$754K 0.02%
1,534
+174
+13% +$79.5K
EL icon
293
Estee Lauder
EL
$31.8B
$751K 0.02%
2,758
-23
-0.8% -$6.92K
TSLA icon
294
Tesla
TSLA
$1.31T
$742K 0.02%
2,067
+672
+48% +$209K
MSCI icon
295
MSCI
MSCI
$40.8B
$739K 0.02%
1,469
+769
+110% +$399K
DD icon
296
DuPont de Nemours
DD
$19.5B
$737K 0.02%
7,975
+1,467
+23% +$143K
VGK icon
297
Vanguard FTSE Europe ETF
VGK
$31B
$736K 0.02%
11,823
-170
-1% -$10.9K
CTVA icon
298
Corteva
CTVA
$50.8B
$731K 0.02%
12,720
+931
+8% +$47.6K
IP icon
299
International Paper
IP
$22.1B
$727K 0.02%
15,759
-342
-2% -$15.7K
CP icon
300
Canadian Pacific Kansas City
CP
$80.8B
$725K 0.02%
8,783
+144
+2% +$10.8K

Similar funds

Bradley Foster & Sargent's Q1 2022 Portfolio in Review

As of Q1 2022, Bradley Foster & Sargent held 496 positions worth $4.68B, down 2.9% from $4.82B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bradley Foster & Sargent's Q1 2022 filing shows 49 new, 233 increased, 148 reduced and 29 closed positions. Its largest new stake was Boston Scientific: 839,214 shares worth $37.2M. The largest sale was T-Mobile US, an estimated $28.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Bradley Foster & Sargent's largest Q1 2022 buy was Boston Scientific: 839,214 shares worth $37.2M.
  • Bradley Foster & Sargent added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $17M increase.
  • Bradley Foster & Sargent's biggest Q1 2022 reduction was T-Mobile US, cutting an estimated $28.9M.
  • Bradley Foster & Sargent fully exited Booz Allen Hamilton in Q1 2022, selling an estimated $2.72M.
  • Bradley Foster & Sargent's ten largest holdings make up 30% of its $4.68B portfolio in Q1 2022.
  • Bradley Foster & Sargent opened 49 new positions and closed 29 in Q1 2022.
  • Bradley Foster & Sargent's portfolio value fell 2.9% quarter-over-quarter to $4.68B.

Based on Bradley Foster & Sargent's 13F filing for Q1 2022, filed 16 May 2022.